GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Net Change in Cash

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Net Change in Cash : $-1.44 Mil (TTM As of Apr. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Advanced Proteome Therapeutics's Net Change in Cash for the three months ended in Apr. 2023 was $-0.81 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Apr. 2023 was $-1.44 Mil.

Advanced Proteome Therapeutics Net Change in Cash Historical Data

The historical data trend for Advanced Proteome Therapeutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Net Change in Cash Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.13 0.82 -0.28

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.22 -0.25 -0.16 -0.81

Advanced Proteome Therapeutics Net Change in Cash Calculation

Advanced Proteome Therapeutics's Net Change in Cash for the fiscal year that ended in Jul. 2022 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.694+-0.014+0.429+0
=-0.28

Advanced Proteome Therapeutics's Net Change in Cash for the quarter that ended in Apr. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.712+-0.1+0+0
=-0.81

Net Change in Cash for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:WESA.X XCNQ:NSHS XCNQ:HAVN XCNQ:ENBI XCNQ:MOOD XCNQ:ABRT TSXV:IBO XCNQ:NIRV XCNQ:AGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY XBRU:ARGX
Traded in Other Exchanges
0E81:Germany APC.H:Canada
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Website
https://www.advancedproteome.com
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018